Dave O'Neill – Managing Director – American West Metals (ASX:AW1) ) is an Australian clean energy mining company focused on growth through the discovery and development of major base metal mineral deposits in Tier 1 jurisdictions of North America.
Copyright 2024 – Finance News Network
Source: Finance News Network
01 Mar 2024 - Nyrada Limited (ASX:NYR) CEO James Bonnar discusses results for using NYR-B103 to treat brain injuries.
Read More20 Nov 2023 - Dotz Nano (ASX:DTZ) navigates global challenges, focusing on carbon capture tech after strategic acquisitions and collaborations. CEO Sharon Malka discusses their resilient approach and plans for growth.
Read More18 Feb 2021 - QEM Limited (ASX:QEM) Managing Director, Gavin Loyden provides an update on the company's flagship Julia Creek vanadium and oil shale project in North Western Queensland, including work on the optimal processing route and the appointment of UK-based engineering consultancy GSA Environmental Limited (GSAe) to conduct vanadium extraction test work on Julia Creek shale.
Read More15 Nov 2022 - OncoSil Medical Limited (ASX:OSL) Non-Executive Director Brian Leedman discusses joining the board of OncoSil and receiving CE mark approval for the company's therapy.
Read More27 Nov 2020 - Novatti Group Limited (ASX:NOV) Managing Director & CEO Peter Cook talks about the company's recently announced partnerships with UnionPay, Google Pay and Samsung Pay.
Read More01 Nov 2019 - IVE Group Limited (ASX:IGL) Executive Chairman, Geoff Selig talks about FY19 results, trends strategy and FY20 outlook.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More30 Jul 2024 - Cristian Moreno - Managing Director - Torque Metals (ASX:TOR) is an exploration company with a proven discovery methodology, combining drilling results with machine learning algorithms and geological interpretation.
Read More27 Apr 2020 - Kazia Therapeutics (ASX:KZA) CEO & MD, Dr. James Garner talks about its Phase II interim results for its glioblastoma drug candidate paxasilib, its pivotal GBM AGILE Phase II clinical study to commence 2H20 and value drivers as the company moves toward registration.
Read More26 Sep 2022 - European Metals Holdings Limited (ASX:EMH) discusses its Cinovec project, the largest hard rock lithium resource in Europe.
Read More
